Harold Bernstein sold $270K of MAZE stock

Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc. (MAZE), sold 10,295 shares of MAZE stock worth $270K, per an SEC Form 4 filed Sep 4, 2026.

It was an open-market sale.

The trade happened on Sep 2, 2026, 2 days before it was made public.

MAZE has moved +28.0% since the trade date, from $26.72 to $34.19 (Nov 6, 2026 close).